Aim: Human chorionic gonadotropin (hCG) is produced by fetal trophoblast cells and secreted into maternal circulation mainly in the first trimester of pregnancy. Another glycoprotein, glycodelin A, is one of the main products of the maternal decidua during this period. The purpose of this study was to investigate the effect of glycodelin A on hCG release by isolated cytotrophoblast cells in vitro. Methods: Cytotrophoblast cells were prepared from human first trimester placenta and incubated with varying concentrations of glycodelin A. Supernatants were assayed for hCG protein concentrations, and quantification of beta hCG mRNA was carried out by RT-PCR. Expression of hCG was analysed in stimulated trophoblast cells and in unstimulated controls by immunocytochemistry. Results: Glycodelin A induces a dose-dependent increase of hCG production. An increase of hCG expression was measured at 100 and 200 mg/mL glycodelin-A treatment in trophoblast cell culture by TaqMan assay on mRNA level. We found a moderate staining of hCG in control trophoblast cells, whereas a strong hCG staining was seen in glycodelin A-treated trophoblast cells. Conclusions: HCG is a marker for the differentiation process of trophoblast cells. Our results suggest that glycodelin A secreted by the decidualized endometrium is involved in the regulation of hormones produced by the trophoblast.
Introduction
Glycodelin, previously known as placental protein 14 (PP14), is expressed in glandular epithelium of the endometrium w20x and decidua w19x. Glycodelin suppresses the cytolytic capacity of NK-cells (Natural Killer Cells) in vitro w32x and it stimulates the Th2-type cytokine production in monocytes w28x, shown by an increased production of IL-6 and IL-10 following glycodelin exposure w25, 26x. Glycodelin directly inhibits T cell activity w39x in an early phase of activation by diminishing T cell responses in the contact site at the time of T cell receptor triggering and inducing T cell apoptosis w38x. Our own investigations w48x suggest a relationship between serum levels of PP14 and threatened abortion, whereby serum PP14 levels were significantly lower in patients with threatened abortion at 10 to 20 weeks of gestation than in normal pregnancies. Glycodelin was shown to have a molecular weight of 28 kDa with two identical subunits held together by non-covalent bonds and a carbohydrate content of 17.5% with a unique carbohydrate configuration. Glycodelin, isolated from amniotic fluid (glycodelin A, GdA), contains fucosylated LacdiNAc structures that are very unusual for mammals w8x. Julkunen and co-workers confirmed the homology between GdA and b-lactoglobulins by deducing its complete amino acid sequence w22x. A similar glycoprotein, glycodelin S, is found in seminal plasma, but it is differentially glycosylated from GdA w23x.
It is assumed that GdA plays an important role during implantation and the early survival of the developing fetoplacental unit. GdA serum levels increase on the 14th day after conception but do not differ from levels in the late secretory phase w21x. A more significant rise of glycodelin A has been found on the 21st and 28th day of pregnancy. The highest serum glycodelin A concentrations have been detected between six and 12 weeks of gestation, followed by a decrease and plateau at 24 weeks. Julkunen et al. w21x measured the content of GdA in amniotic fluid and found the highest values between the 12th and 20th week of gestation with a highest level of 232 mg/mL. This is nearly one thousand fold higher than the serum glycodelin A for equivalent gestational age. Even early radioimmunoassays established that the GdA secretory pattern resembles that of human chorionic gonadotropin (hCG) w42x. Because these two proteins are different with regards to their tissue of origin (GdA is produced by maternal decidua but hCG is produced by fetal trophoblast), no functional relationship between hCG and GdA is suggested. It is generally accepted that hCG is produced by the syncytiotrophoblast w45x, but Hoshina et al. w12x and Boime w3x speculated that hCG could also be produced by cytotrophoblast cells, although the regulation of placental hCG-b expression is still not well understood w27x. In a preliminary study we investigated the expression of bhCG mRNA in panels of different human normal tissues and isolated term trophoblast cells w40x. We found a bhCG stimulation by glycodelin A on mRNA level. The effect of glycodelin A on bhCG regulation is time-dependent. We observed a short increase of bhCG mRNA copy numbers 60 min after glycodelin A treatment. In another study, normal preparations of human term trophoblast cells in vitro were used to investigate the effect of glycodelin A on endocrine trophoblast function by measuring the release of hCG in culture medium w17x. Because production of both GdA and hCG are highest in the first trimester of pregnancy, we undertook the present study to investigate the influence and relationship of glycodelin A on bhCG-mRNA and protein expression in isolated first trimester trophoblast cells.
Materials and methods
Placental tissue was obtained from terminations of normal pregnancies between the seventh and 12 th week of gestation. A total of 14 placentas was obtained after curettage treatment. All women were between 22 and 36 years, had a singleton pregnancy and showed no abnormalties until the moment of termination. The study was approved by the ethical committee of the University of Rostock, and informed consent to use the tissue was obtained from each patient.
Dulbecco's modified Eagle's medium (DMEM), Hank's balanced salt solution (HBSS) without Ca 2q and Mg 2q , antibiotic and antimycotic solutions, Ultroser G and trypsin-EDTA were obtained from GibcoBRL Life Technologies (Paisley, UK). Trypsin type 3 and DNAse I were obtained from Sigma (Taufkirchen, Germany) and HEPES buffer (1M) and inactivated fetal calf serum (FCS) came from Biochrom (Berlin, Germany).
Preparation and culture of villous cytotrophoblast cells
CTBs were prepared according to a published protocol w15x. Briefly, first trimester placental tissue was minced and digested three times with trypsin and DNAse I in HBSS-HEPES. First purification was performed on a percoll gradient. After centrifugation, CTBs were aspirated and the villous cytotrophoblast cells were immunopurified using antibodies against CD45 and CD9 (Dianova, Hamburg, Germany) and a magnetic cell sorting column (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) to eliminate contaminating leukocytes (CD45), extravillous trophoblast cells, fibroblasts and other mesenchymal components (CD9). The identity of the isolated villous cytotrophoblast cells was determined morphologically by light microscopy and by immunostaining with a monoclonal mouse anti-cytokeratin 7 antibody (Progen Biotechnik, Heidelberg, Germany). In addition, cells were checked for possible expression of the Thomsen-Friedenreich epitope, which is a marker for syncytiotrophoblast w15x. Isolated cells contained less than 1% digested fragments of the syncytiotrophoblast. Cells were cultured in DMEM medium with 10% inactivated FCS and with antibiotics and antimycotics.
Purification of glycodelin A from amniotic fluid
Glycodelin A was purified from amniotic fluid obtained from the pooled samples obtained from women with normal singleton pregnancies that for diagnostic purposes by two anion exchange chromatography steps, gel filtration and two hydrophobic interaction chromatography steps as described elsewhere w17x. Briefly, amniotic fluid was loaded onto a DEAE-Sepharose column and fractionated on a 50-500 mM NH 4 HCO 3 -gradient followed by gel filtration and a second anion exchange chromatography step on Resource Q. Final purification was obtained by hydrophobic interaction chromatography on Octyl-Sepharose and Resource-Phe (all columns by Amersham Pharmacia Biotech AB, Uppsala, Sweden).
Identification of glycodelin A by Western blot analysis
Western blot analysis of purified glycodelin A was carried out according to the procedure published elsewhere w2x. Briefly, glycodelin A was detected with a polyclonal rabbit anti glycodelin A antibody (10 mg/mL, Bioscience, Berlin, Germany) followed by anti-rabbit IgG conjugated to HRP (1:1000, Dianova, Hamburg, Germany) and stained with 3-amino-9-ethyl carbazol (Sigma).
Treatment of trophoblast cultures with glycodelin A
Freshly isolated trophoblast cells were incubated at concentrations of 1=10 6 cells/mL in 24-well plates (Greiner Labortechnik, Solingen, Germany) in humidified 5% CO 2 -95% air at 378C in the presence of 50 mg/mL, 100 mg/mL and 200 mg/mL glycodelin A. Untreated cell cultures of the same placentas were used as controls. In addition, samples of the transferrin containing fraction of amniotic fluid were also used as controls to verify the effect of glycodelin A. The effect of glycodelin A on the secretion of markers for syncytiotrophoblasts was studied by comparing the kinetics of hCG mRNA or protein production of untreated (controls) and glycodelin A-stimulated trophoblast cell cultures simultaneously. All experiments were carried out at least in triplicates.
Identification of hCGb-mRNA transcripts (real-time RT-PCR)
Total RNA was prepared using the acid guanidium thiocyanatephenol-chloroform protocol w6x. Quality of the RNA samples was determined by electrophoresis through denaturing agarose gels and staining with ethidium bromide. The RNA was quantified and evaluated for purity by UV spectrophotometry. To further assess the quality of RNA, all specimens were tested by analysis of housekeeping gene expression using conventional RT-PCR.
HCG-b primers and probe were designed using the Primer Expressீ 1.0 program (PE Applied Biosystems, Foster City, CA). Oligonucleotide hybridisation probe and primers with the following sequences were synthesized as follows: TaqManீ probe 59-CTG CTG AGC ATG GGC GGG ACA T (exon 2), forward primer 59-CCA AGG ATG GAG ATG TTC CAG, and reverse primer 59-GCA CGC GGG TCA TGG T. The reverse primer was designed to span an exon/intron junction to avoid amplification of DNA sequences, whereas the forward primer was complementary to the 39-end of exon 1. Primers and probe were obtained from Applied Biosystems GmbH (Weiterstadt, Germany). The primers yielded a RT-PCR product of 199 nucleotides w40x.
The preparation of RNA standard and quantification of bhCG mRNA expression by ABI PRISM 7700 Sequence Detection System (PE Applied Biosystems) have been published in detail previously w40, 41x. The TaqMan ᮋ EZ RT-PCR Kit (PE, Applied Biosystems) was used for reverse transcription and amplification of both targets and standards. All RT-PCR reactions were performed in triplicate with a final volume of 25 mL. RT-PCR conditions were optimised for primers (300 nM), probe (100 nM), template (100 ng), and manganese acetate concentrations (3 mM). The reaction conditions were 2 min at 508C, 30 min at 608C, 2 min at 958C, 40 cycles with 20 sec at 948C and 1 min at 608C w41x.
Analysis of hCG protein production
At designated times (24 h and 48 h) aliquots of the culture media were taken, frozen at y408C and replaced with fresh medium. Cells were cultured for up to 48 h. Secretion of hCG was analysed by the automated hormone analyser ''Immulite'' (DPC Biermann GmbH, Bad Nauheim, Germany). This assay detects, besides normal hCG, the five irregular forms of bhCG including hyperglycosylated hCG. The results of this assay agree with those of the RIA, and it avoids false-positive values in the samples tested w7x. The sensitivity of the used assay is 1.1 mIU/mL, and the detection limit is 5000 mIU/mL.
Immunocytochemistry
Isolated trophoblast cells were incubated with varying concentrations of glycodelin (0, 100 mg/mL and 200 mg/mL) and grown on three-well multitest slides (Roth, Karlsruhe, Germany) for up to 72 h. At designated times, medium was withdrawn, the slides were air-dried, wrapped and stored at y808C. After thawing, the cells were briefly fixed with formalin (Merck, Darmstadt, Germany; 5% in PBS, 5 min) and permeabilized with digitonin (Ysat, Wernigerode, Germany; 6 mg/mL in PBS, 15 min). The antibody against hCG was diluted to 5 mg/mL with PBS and incubated with the slides overnight at 48C. As isotype controls of the antihCG antibody normal mouse serum as well as a monoclonal antibody against Glycodelin A (A87-B/D2, IgG) were incubated with different slides overnight at 48C. After washing, Cy3-labelled goat anti-mouse IgG, diluted 1:200, were used as second antibodies for staining of hCG. Slides were examined with a Zeiss (Jena, Germany) Axiophot photomicroscope. Digital images were obtained with a digital camera system (Axiocam; Zeiss) and saved on computer.
Statistical analysis
The SPSS/PC software package, version 6.01 (SPSS GmbH, Munich, Germany), was used for collection, processing, and statistical analysis of all data. Statistical analysis was performed using the non parametrical Wilcoxon's signed rank tests for comparison of the means. P-0.05 was considered statistically significant.
Results

Purification of glycodelin A from amniotic fluid
SDS-PAGE of the purified protein showed one band at 28 kD (Figure 1, Lane 1) . In addition, the purified protein was checked for impurities of hCG by the automated hormone analyser ''Immulite'' (DPC Biermann GmbH, Bad Nauheim, Germany) and did not contain any hCG traces. Identity of purified glycodelin A was checked by Western blot analysis (Figure 1, Lane 2) .
Stimulation of hCGb-mRNA production by glycodelin A
An increase of hCGb-mRNA expression was measured at 100 mg/mL and 200 mg/mL glycodelin A-treatment in trophoblast cell cultures by the TaqManீ assay. No significant change of bhCG mRNA expression was seen in the untreated control (Figure 2) . Time-and dose-dependency studies showed that the highest number of copies was measured at the higher dose (200 mg/mL) after as little as 30 min, whereas with the lower dose (100 mg/ mL) 60 min were required. In both cases the increase was 
Figure 3
Effect of glycodelin A on the hCG production of cytotrophoblast cells in vitro. Data (mean"SD) represent hCG concentration in aliquots of the culture media at designated times (ns4 for every group). Ps0.036 (100 mg/mL glycodelin A) and Ps0.028 (200 mg/mL glycodelin A) indicates the significance levels between controls and stimulated cultures. There was no significant difference observed between the hCG production of controls and cells stimulated with 50 mg/mL glycodelin A (P)0.05). statistically significant (Ps0.046 and 0.028, respectively). After 90 min, mRNA levels were almost indistinguishable from the controls.
Stimulation of hCG protein production by glycodelin A
The concentrations of hCG released by trophoblast cells, incubated for 24 or 48 h with different concentrations of glycodelin A (0, 50, 100, 200 mg/mL) are shown in Figure   3 . The data indicate that glycodelin A stimulates hCG protein production in trophoblast cells in a time and dose-dependent manner. When trophoblast cells were incubated with glycodelin A (50 mg), no significant rise (Ps0.624) of hCG production was observed. A significant increase in hCG production was found for higher concentrations of glycodelin A (100 mg/mL Ps0.036; 200 mg/mL Ps0.028) after prolonged incubation (48 h). Addition of 100 mg/mL glycodelin A led to a rise of the hCG level by the factor 2.2, whereas addition of 200 mg/mL led to a rise of the hCG levels by the factor 3.7.
The transferrin containing fractions of amniotic fluid had no effect on the hCG production of trophoblast cells and showed the same values of hCG production as controls. 216 Jeschke et al., hCG stimulation and glycodelin Article in press -uncorrected proof 
Expression of hCG on CTB as detected by immunofluorescence
Comment
The physiological role of hCG during pregnancy is not completely understood. It is generally assumed that hCG production by the trophoblast stimulates progesterone secretion, thus contributing to the maintenance of the corpus luteum of pregnancy. Expression of hCG is detectable as early as at the eight cell stage of the developing embryo w4x. An array of paracrine modulators of hCG synthesis has been identified w14, 18, 29, 33x, but less is known about the regulatory elements of the hCGb gene because highly differentiated cells are required for their regulation w1x.
This study shows that glycodelin A stimulates hCG in isolated trophoblast cells in vitro at mRNA level. In addition, glycodelin A caused an increase in hCG release by cultivated cytotrophoblast cells into the medium. This increase was dose-dependent. Addition of 50 mg/mL glycodelin A did not lead to a significant increase of hCG secretion. Addition of higher concentrations (100 mg/mL and 200 mg/mL) of glycodelin A induced a significant increase in secretion of hCG compared to unstimulated controls in trophoblast cells. The range of concentrations of glycodelin used for the experiments is similar to the physiological range of this glycoprotein as found in amniotic fluid during the first trimester of pregnancy w44x. The glycodelin concentration rises during the first eight to nine weeks of gestation, and is maintained until 14-15 weeks of gestation w21x. During this time of pregnancy, fetus-derived trophoblast cells invade deeply into the maternal decidua, and the contact between fetal and maternal cells is most intimate w9x. Glycodelin A is the main product of the decidua in the first trimester of pregnancy w19, 43x, whereas also IGF-BP1 and prolactin are synthesized and secreted in high levels by decidual cells w5, 10, 11, 13, 24, 31, 34, 47, 46x. Our results suggest a stimulating effect of glycodelin A on hCG secretion of trophoblasts. To investigate a possible induction of hCG synthesis in trophoblasts by glycodelin A, real time RT-PCR was used. The results showed a dose dependent stimulating effect of glycodelin A of trophoblasts on the bhCG mRNA level. There was no significant rise of hCGb mRNA in unstimulated controls. The addition of high amounts of glycodelin A (200 mg/mL) led to an immediate increase of bhCG mRNA copy numbers by the factor 3 after only 30 min of incubation compared to unstimulated controls. Addition of 100 mg/mL glycodelin A led to an immediate increase of bhCG mRNA copy numbers by the factor 2 after 60 min of incubation. This immediate stimulation effect was also observed in former studies, where glycodelin A stimulated bhCG mRNA synthesis in term trophoblast cells w40x as well as in Jeg 3 trophoblast tumor cells w2x. A delayed stimulation of hCG protein production by glycodelin A was measured in both cell types, which could be explained by a feedback inhibition of the bhCG mRNA synthesis by hCG itself. Feedback inhibition of gene expression is a widespread phenomenon in which the expression of a gene is downregulated by its protein product. Feedback in eukaryotic cells involves time delays resulting from transcription, transcript splicing and processing, and protein synthesis w30x.
Thus, our results show that glycodelin A induces both bhCG mRNA synthesis and secretion of hCG in trophoblast cells, although the exact mechanism of action of 
